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Following entry and reverse transcription, the HIV-1
genome is integrated into the host genome. In contrast to
productively infected cells, latently infected cells fre-
quently harbor HIV-1 genomes integrated in heterochro-
matic structures, allowing persistence of transcriptionally
silent proviruses. Microglial cells are the main HIV-1
target cells in the central nervous system and constitute
an important reservoir for viral pathogenesis. In the
present work, we show that, in microglial cells, the
co-repressor COUP-TF interacting protein 2 (CTIP2)
recruits a multienzymatic chromatin-modifying complex
and establishes a heterochromatic environment at the
HIV-1 promoter. We report that CTIP2 recruits histone
deacetylase (HDAC)1 and HDAC2 to promote local histone
H3 deacetylation at the HIV-1 promoter region. In addi-
tion, DNA-bound CTIP2 also associates with the histone
methyltransferase SUV39H1, which increases local
histone H3 lysine 9 methylation. This allows concomitant
recruitment of HP1 proteins to the viral promoter and
formation of local heterochromatin, leading to HIV-1 silen-
cing. Altogether, our findings uncover new therapeutic
opportunities for purging latent HIV-1 viruses from their
cellular reservoirs.
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Introduction
After entry into the target cell and reverse transcription, HIV-1
genes are integrated into the host genome. It is now well
established that the viral promoter activity is directly gov-
erned by its chromatin environment (reviewed in Van Lint,
2000). Nucleosomes are precisely positioned at the HIV-1
promoter (Verdin et al, 1993; Van Lint et al, 1996). Nuc-1,
a nucleosome located immediately downstream of the tran-
scriptional initiation site directly impedes LTR activity.
Epigenetic modifications and disruption of Nuc-1 are a pre-
requisite to activation of LTR-driven transcription and viral
expression (for review, see Van Lint, 2000). The compaction
of chromatin and its permissiveness for transcription are
directly dependent on the post-translational modifications
of histones such as acetylation, methylation, phosphorylation
and ubiquitination (reviewed in Fischle et al, 2003).
Euchromatin, a relaxed state of chromatin, is often associated
with active transcription. On the other hand, heterochroma-
tin, a compacted and more structured chromatin environ-
ment, is repressive for transcription. In contrast to
productively infected cells, latently infected cells frequently
harbor HIV-1 genomes integrated in heterochromatic struc-
tures, which allows viral persistence of silenced integrated
proviruses (Jordan et al, 2003). These observations might at
least partially explain how the virus can escape the host
immune response and current therapeutic tools (Finzi et al,
1997; Pierson et al, 2000). Understanding the molecular
mechanisms underlying HIV-1 transcriptional silencing is
thus a major challenge in the fight against AIDS.
HP1a is associated with transcriptionally inactive chroma-
tin. At heterochromatic sites, HP1 binds methylated lysine 9
of histone H3 where it promotes gene silencing (Bannister
et al, 2001). Transition from an active to inactive trans-
criptional state implies a series of ordered recruitment of
histone-modifying enzymes. This is exemplified for K9/H3
methylation and HP1 recruitment, which requires the
stepwise recruitment of histone deacetylase (HDAC) (to first
remove the acetyl group) and histone methyltransferase
(HMT) activities.
HIV-1 gene transcription has been shown to be activated
by trichostatin A (TSA) treatment, and several transcription
factors bound to the viral LTR recruit class I or II HDAC (Van
Lint et al, 1996; Coull et al, 2000; Williams et al, 2006).
However, to date, the mechanisms associated with the estab-
lishment of a heterochromatic environment at the HIV-1
promoter remains unclear.
COUP-TF interacting protein 2 (CTIP2) is a recently cloned
transcriptional repressor that can associate with members
of the COUP-TF family (Avram et al, 2000). This cofactor is
expressed in the brain and the immune system (Leid et al,
2004). By regulating both differentiation and survival of
thymocytes, CTIP2 is necessary for T-lymphocyte develop-
ment (Wakabayashi et al, 2003). In the brain, CTIP2 plays a
key role in the development of corticospinal motor neuron
axonal projections to the spinal cord (Arlotta et al, 2005).
Recently, we reported that CTIP2 inhibits HIV-1 replication
in human microglial cells (Rohr et al, 2003; Marban et al,
2005). Microglial cells constitute the central nervous system
(CNS)-resident macrophages. They are the main HIV-1
target cells in the brain, and because they are long lived
and relatively protected by the blood–brain barrier, theyReceived: 27 June 2006; accepted: 29 November 2006
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constitute an important reservoir of viruses. Recently, brain
macrophages have been described as latently HIV-1-infected
cellular reservoirs (Barber et al, 2006). It is now clear that the
long-lived reservoirs of HIV-1 can persist for years in the
presence of HAART. However, contrary to CD4þ T-lympho-
cyte reservoirs (reviewed in Marcello, 2006), information on
the virus state within macrophages and microglial cells is
very limited.
Here, we report that CTIP2 inhibits HIV-1 gene transcrip-
tion by recruiting a chromatin-modifying complex and by
establishing a heterochromatic environment at the HIV-1
promoter in microglial cells. Understanding HIV-1 silencing
in the cellular reservoirs is actually the major challenge to
viral eradication. Thereby, CTIP2, HDAC and HMT recruit-
ments might uncover new therapeutic opportunities.
Results
CTIP2 associates with TSA-sensitive HDAC activities
Our previous studies (Rohr et al, 2003; Marban et al, 2005)
suggested that CTIP2 may repress HIV-1 transcription
through association with HDAC activities in microglial cells.
To decipher whether TSA-sensitive HDACs participate in
CTIP2 repressive function, we examined the effect of TSA,
a compound known to inhibit class I and II but not class III
HDACs, on CTIP2-mediated repression of HIV-1 promoter in
microglial cells (Figure 1A). TSA treatment and CTIP2 knock-
down stimulated LTR-driven transcription in microglial cells.
Interestingly, CTIP2 knockdown and TSA treatment strongly
synergyized in HIV-1 transcriptional activation, suggesting an
interaction of CTIP2 and TSA-sensitive HDACs (Figure 1A). Of
note, control and HDAC3 shRNAs did not activate LTR-driven
transcription, alone or in cooperation with TSA treatment
(Supplementary Figure 1A). The specificity of CTIP2 knock-
down and TSA cooperation in HIV-1 transcription was
assessed by testing other cellular and viral promoters. No
significant cooperation was observed in the modulation of the
tested promoters (Supplementary Figure 1B). To test whether
CTIP2 could associate with HDAC activity, FLAG-tagged
CTIP2 was immunoprecipitated from HEK cell extracts and
associated HDAC activity was assessed. As shown in
Figure 1B, CTIP2 associated with robust HDAC activity. By
comparison, the relative amount of HDAC activity associated
with CTIP2 was about nine-fold higher than that observed
with the control immunoprecipitation. Interestingly, TSA
totally abolished CTIP2-associated HDAC activity, demon-
strating that this activity was due to class I or II HDACs.
CTIP2 associates with HDAC1 and HDAC2
Based on the above findings, we next tested the presence of
HDAC1–3 in the material associated with CTIP2 (Figure 1C).
Western blot analysis revealed that CTIP2 specifically asso-
ciated with HDAC1 and HDAC2 but not with HDAC3.
Association of CTIP2 with HDAC1/2 in microglial cells was
confirmed by immunofluorescence confocal microscopy
(Supplementary Figure 2). Altogether, these results demon-
strate that CTIP2 associates with an active HDAC complex.
Several multiproteic complexes containing HDAC1 and
HDAC2 have been described, such as Sin3, NuRD or Co-
REST. To further investigate the nature of CTIP2-associated
HDAC complex, Western blot analysis was performed on
affinity-purified CTIP2-associated complex from HEK 293T
cell extracts. Although Sin3, NuRD and Co-RESTwere present
in CTIP2-expressing cells, no interaction was detected with
CTIP2 (data not shown). This suggests that CTIP2 may not
be involved in any of the HDAC1/2-containing complexes
identified to date.
The HDAC-interacting domain of CTIP2 is located in its
N-terminus
To delineate the CTIP2 region mediating HDAC interaction,
we performed HDAC activity assays on affinity-purified
materials from cells expressing truncated mutants of CTIP2
(Figure 2A). The N-terminal part of CTIP2 (aa 1–354) was
sufficient to recruit 80% of the HDAC activity associated with
the full-length CTIP2 (Figure 2A, compare columns 5 and 3).
Interestingly, neither the 145–434 nor the 350–813 region is
associated with significant HDAC activity, suggesting that aa
1–145 of CTIP2 are responsible for HDAC recruitment.
To verify the correlation between CTIP2-associated HDAC
activity and the presence of HDAC1/2, we performed Western
blot analysis of the material associated with the various
CTIP2 mutants (Figure 2B). As expected, the full-length and
the N-terminal part of CTIP2 associated with endogenous
HDAC1 and HDAC2.
HDAC1 and HDAC2 cooperate with CTIP2 to repress
HIV-1 gene transcription and viral replication
To decipher how HDAC1 and HDAC2 participate in CTIP2-
repressive function, we examined their effect on CTIP2-
mediated repression of chromatin-integrated HIV-1 promoter.
TZM-bl cells, which contain a chromatin-integrated LTR,
were cotransfected with expression vectors for CTIP2,
HDAC1 or HDAC2, as indicated. Overexpression of HDAC1
and HDAC2 alone did not significantly affect LTR-driven
transcription (Figure 3A). Moreover, CTIP2-mediated repres-
sion was further enhanced by coexpression of HDAC1 or
HDAC2. Similar results were obtained in microglial cells
transfected with an episomal LTR-LUC reporter (Figure 3B).
Of note, a mutant of CTIP2 deficient in HDAC1/2 binding
(i.e. 145–434 mutant) did not cooperate with HDAC1/2
(Supplementary Figure 3A). To validate the biological
Figure 1 Interactions of TSA-sensitive HDAC1 and HDAC2 with
CTIP2. (A) Microglial cells were transfected with the episomal
LTR-LUC vector in the presence or absence of 4 mg of pshRNA-
CTIP2 vector. Cells were untreated or treated with 450nM TSA for
24 h. Two days post-transfection, LUC activities were measured and
expressed relative to the value obtained with the empty vector. The
knockdown efficiency of shRNA construction was controlled by
Western blot (Supplement Figure 5A). Control shRNAs are also
presented (Supplement Figure 1A). (B, C) HEK 293T cells were
transfected with the indicated pFLAG-CTIP2 expression vector and
the empty vector as control. Immunoprecipitated complexes were
tested for HDAC activities (B) and for the presence of HDAC1,
HDAC2 and HDAC3 by Western blot (C).
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relevance of our finding, we next investigated the effect of
knocking down CTIP2, HDAC1 and HDAC2 on HIV-1 LTR-
driven transcription. Knockdown of HDAC1 or HDAC2 had
very little to no impact on HIV-1 transcription, whereas
knockdown of CTIP2 increased LTR transcriptional activity,
both on integrated and on episomal HIV-1 LTR (Figure 3C
and D). However, simultaneous knockdown of CTIP2 and
HDAC1 or HDAC2 led to further increase HIV-1 transcription.
To determine the impact of CTIP2-mediated recruitment
on HIV-1 replication, microglial cells were transfected with
the HIV-1 pNL4-3 vector together with expression vectors
for CTIP2, HDAC1 and HDAC2, as indicated (Figure 3E).
Forty-eight hours post-transfection, soluble p24 capsid
protein was assessed in the culture medium by ELISA.
As expected, overexpression of HDAC1 or HDAC2 did
not affect HIV-1 replication significantly. In contrast, over-
expression of CTIP2 was associated with a dramatic inhibi-
tion of HIV-1 replication, which was further enhanced by
coexpression of HDAC1 or HDAC2 (Figure 3E). To further
evaluate the functional cooperation of endogenous CTIP2
and HDAC1/2 enzymes, we quantified p24 production in
HIV-1-infected microglial cells that had been knocked
down for CTIP2, HDAC1 or HDAC2, alone or in combination,
as indicated (Figure 3F). HDAC1 or HDAC2 knockdown
only slightly stimulated HIV-1 replication. In contrast,
knockdown of CTIP2 stimulated HIV-1 production up to
60-fold, thus confirming the repressive function of CTIP2
in microglial cells. More importantly, simultaneous knock-
down of CTIP2 together with either HDAC1 or HDAC2
enhanced viral production up to 170-fold (Figure 3F).
Altogether, these observations demonstrate a functional
cooperation between CTIP2 and HDAC1/2 in HIV-1 gene
silencing.
Association of CTIP2 with the HIV-1 proximal promoter
induces recruitment of HDAC1 and HDAC2 and local
histone H3 deacetylation
We previously reported that CTIP2 was recruited to the HIV-1
promoter by the cellular transcription factor Sp1 (Marban
et al, 2005). To determine whether endogenous CTIP2,
HDAC1 and HDAC2 proteins are associated at the viral
promoter, microglial cells were infected with an NL4.3-env
HIV-1 virus and recruitment of CTIP2, Sp1, HDAC1 and
HDAC2 was analyzed by chromatin immunoprecipitation
(ChIP) (Figure 4A). CTIP2 and Sp1 were found at the prox-
imal region of the HIV-1 promoter (PCR1) (Figure 4A). In
addition, both HDAC1 and HDAC2 were detected bound at the
same region of the promoter. As a control, no binding of
CTIP2, Sp1, HDAC1 or HDAC2 was observed for the control
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) pro-
moter (data not shown). We next investigated whether
HDAC1 and HDAC2 are recruited to the HIV-1 promoter by
CTIP2. As expected, CTIP2 associated specifically with the
LTR proximal region, but not with the Nuc-1-binding region
(Figure 4B). Overexpression of CTIP2 increased recruitment
of HDAC1 and HDAC2 to the Sp1-binding site (Figure 4B,
panels a-HDAC1 and a-HDAC2, PCR1) and to the Nuc-1-
binding region (Figure 4B, panels a-HDAC1 and a-HDAC2,
column PCR2) of the LTR. As a control, overexpression
of the N-terminal truncated 145–434 proteins did not
increase HDAC1 and HDAC2 binding to the viral promoter
(Supplementary Figure 3E).
We next assessed the impact of HDAC1/2 recruitment at
the HIV-1 promoter by CTIP2 on local acetylation levels. For
this purpose, we examined the acetylation of histone H3 at
the Nuc-1-binding region and as a control at the proximal
promoter region (Figure 4B, PCR2 and PCR1 respectively).
No Ac/H3 was detected on the HIV-1 proximal promoter in
the absence of CTIP2, whereas acetylated histones H3 were
observed at the HIV-1 Nuc-1-binding region and at the
constitutively active GAPDH promoter (Supplementary
Figure 3C). Interestingly, overexpression of CTIP2 resulted
Figure 2 CTIP2 associates with HDAC1 and HDAC2 via its
N-terminal domain. (A, B) HEK 293T cells were transfected with
the indicated pFLAG-CTIP2 constructs and the empty vector as
control. Cells extracts were normalized for the quantities of over-
expressed FLAG-CTIP2 proteins and endogenous HDAC1 and
HDAC2. Immunoprecipitated complexes were tested for HDAC
activities (A) and for the presence of HDAC1, HDAC2 and FLAG-
CTIP2 proteins by Western blot (B). (B) Input controls for HDAC1,
HDAC2 (columns 1–5) and FLAG-CTIP2 construct expression
(a-FLAG panel) are presented. A schematic CTIP2 linear structure
is also drawn for a better visualization of CTIP2 domains.
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in decreased levels of histone H3 acetylation at the HIV-1
Nuc-1-binding region (Figure 4B, panel a-Ac/H3, PCR2). As
a control, no enrichment of Ac/H3 was observed at the
proximal promoter (Figure 4B, panel a-Ac/H3, PCR1).
These results suggest that CTIP2 targets HDAC1 and HDAC2
to the HIV-1 gene promoter to establish a chromatin environ-
ment detrimental to transcription. This conclusion was sup-
ported by the CTIP2-mediated repression of LTR-driven
transcription in 293T cells (Figure 4C).
To further explore the link between CTIP2 and association
of HDAC1 and HDAC2 with the viral promoter, we performed
ChIP experiments in a context of HIV-1-infected control and
CTIP2 knockdown microglial cells. As expected, reduction
of endogenous CTIP2 levels correlated with decreased
binding at the HIV-1 proximal promoter region (Figure 4D,
panel a-CTIP2). As control, the same amount of Sp1
(Figure 4D, panel a-Sp1) was found at the proximal promoter
region in control and CTIP2 knockdown cells. Surprisingly,
whereas HDAC2 binding at the viral promoter was reduced
in CTIP2 knockdown cells (Figure 4D, panel a-HDAC2),
HDAC1 recruitment was enhanced (Figure 4D, panel
a-HDAC1). Together with the results from previous studies
(Doetzlhofer et al, 1999), this observation suggests that
displacement of the CTIP2-repressing complex may allow
additional HDAC1 protein to interact via Sp1 with the viral
promoter. To further explore the role of CTIP2 in HIV-1 gene
transcription, we quantified the initiated and the elongated
transcripts in the context of HIV-1-positive microglial cells,
knocked down for CTIP2. As shown in Figure 4E, the relative
amount of HIV-1-initiated transcripts was eight times
Figure 3 HDAC1 and HDAC2 cooperate with CTIP2 to repress HIV-1 gene transcription and viral replication. (A, C) TZM-bl cells were
transfected with the indicated plasmids. Two days post-transfection, LUC activities were measured and expressed relative to the value obtained
with the empty vector. (B, D) Microglial cells were transfected with the episomal LTR-LUC and the indicated vectors. LUC activities were
measured 2 days post-trasnfection and expressed relative to the value obtained with LTR-LUC alone. DNA quantities were normalized with the
corresponding empty vector. (E, F) Microglial cells were transfected with pNL4-3 and the indicated vectors. Culture supernatants were
analyzed for p24 Gag contents 48 h post-transfection. The knockdown efficiency of shRNA constructions was controlled by Western blot
(Supplement Figure 5A).
Silencing of HIV-1 gene transcription via CTIP2
C Marban et al
&2007 European Molecular Biology Organization The EMBO Journal VOL 26 | NO 2 | 2007 415
increased in CTIP2 knockdown cells compared to control
cells. CTIP2 promoted accumulation of initiated transcripts
but did not significantly increase elongated transcripts under
these experimental conditions (Figure 4E).
CTIP2 associates with histone methyltransferase
SUV39H1
We have previously reported that CTIP2 promotes HP1a
recruitment to the HIV-1 promoter (Marban et al, 2005). In
heterochromatic environments, HP1a associates with the
methylated form of histone H3 lysine 9 (Bannister et al,
2001). As methylation of H3/K9 is typically mediated by
SUV39H1, we logically tested whether CTIP2 is associated
with SUV39H1. As shown in Figure 5, endogenous SUV39H1
was copurified with immunoprecipitated FLAG-tagged CTIP2
(Figure 5A, lane 1). In addition, deletion analysis revealed
that the central 145–434 domain (Figure 5A, lane 3) but not
the N- and C-terminal domains (Figure 5A, lanes 2 and 4) of
CTIP2 was sufficient to mediate interaction with SUV39H1.
The association of SUV39H1 with CTIP2 was further tested
in vitro (Figure 5B). Pull-down experiments with in vitro-
translated CTIP2 showed that 2–5% of CTIP2 proteins
specifically interacted with GST-SUV39H1 in vitro (Figure 5B,
column 3). Finally, confocal microscopic observations
revealed colocalization of CTIP2 and SUV39H1 in the nuclei
of microglial cells (Supplementary Figure 4).
CTIP2 cooperates with SUV39H1 to repress HIV-1 gene
transcription and viral replication
To further characterize the significance of CTIP2/SUV39H1
interaction, we performed luciferase assays on cellular ex-
tracts from TZM-bl cells containing an integrated LTR-LUC
construct (Figure 5C) and from microglial cells transfected
with an episomal LTR-LUC reporter (Figure 5D). The effects
of CTIP2 and SUV39H1 were assessed after overexpression
of each protein, independently or in combination.
Overexpression of SUV39H1 alone had no effect on LTR-
driven transcription (Figure 5C and D, column 2). However,
it dramatically increased CTIP2-mediated repression of the
HIV-1 promoter (Figure 5C and D, column 4). As a control,
SUV39H1 had no effect on the aa 1–354 truncation CTIP2
mutant, which is unable to interact with SUV39H1
(Supplementary Figure 3B). These results suggest a func-
tional cooperation between CTIP2 and SUV39H1 in the con-
text of chromatinized HIV-1 promoter in microglial cells.
Next, similar experiments were performed using shRNA
constructs targeting SUV39H1 and CTIP2 (Figures 5E and
F). As expected knockdown of CTIP2 and SUV39H1 indepen-
dently or in combination stimulated transcription from gen-
ome-integrated as well as episomal HIV-1 LTR. The functional
relevance of CTIP2/SUV39H1 to HIV-1 replication was
next examined. For this purpose, CTIP2 and increasing
amounts of SUV39H1 were expressed in pNL4-3-transfected
microglial cells (Figure 5G). Production of p24 HIV-1 capsid
Figure 4 Association of CTIP2 with the HIV-1 proximal promoter induces local H3 deacetylation with concomitant recruitment of HDAC1 and
HDAC2. (A, D) Microglial cells (A) and CTIP2 knockdown cells (D) were infected with the VSV-pseudotyped pNL4.3-env virus 24 h before
being subjected to ChIP experiments with the indicated antibodies. As a control, immunoprecipitations were performed in the absence of
antibody (Ab control). Input (1/1000) and immunoprecipitated DNAs were quantified by real-time PCR using PCR1 LTR-specific oligonucleo-
tides. The amount of immunoprecipitated material was normalized to the input DNA (A) and fold enrichments were normalized to the
nonspecific enrichment in the GAPDH DNA (D). (B) ChIP experiments were performed on HEK 293Tcells transfected with the HIV-1 LTR-LUC
episomal vector in the presence or absence of the FLAG-CTIP2 expression vector as indicated. Cells were subjected to ChIP assays with the
indicated antibodies. Specific enrichments in HIV LTR regions were quantitated by real-time PCR with the PCR1, PCR2 and GAPDH
oligonucleotides. Results were normalized to enrichment in nonspecific GAPDH DNA. Results are representative of three independent
experiments. (C) LTR-LUC-transfected HEK 293Tcells were subjected to LUC activity quantification in the presence or absence of overexpressed
CTIP2. (E) Initiated and elongated HIV-1 gene transcripts were quantitated by real-time RT–PCR in HIV-1-infected control and CTIP2
knockdown microglial cells. PCR quantifications target the HIV-1 TAR (initiation) and the HIV-1 Tat (elongation) regions. Results are presented
relative to the initiated transcripts in control cells and normalized to b-actin copies.
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was unaffected by overexpression of SUV39H1 (Figure 5G).
However, in the presence of CTIP2, SUV39H1 further
enhanced CTIP2-mediated repression of viral replication,
confirming a functional cooperation between both proteins.
As expected, the functional cooperation between CTIP2
and SUV39H1 was also observed in a similar experi-
mental setting using knockdown of CTIP2 and SUV39H1
(Figure 5H).
CTIP2-mediated recruitment of SUV39H1 to the HIV-1
proximal promoter induces K9/H3 methylation and HP1
association
K9/H3 methylation is the ultimate epigenetic modification
necessary for HP1 association and polymerization. To deter-
mine whether endogenous CTIP2, SUV39H1 and HP1 pro-
teins are associated with the viral promoter in the context of
infected microglial cells, cells were infected with a vesicular
stomatostatis virus (VSV)-pseudotyped HIV-1 NL4.3-env
virus 24 h before being processed for ChIP experiments
(Figure 6A). The presence of CTIP2, HDAC2 and HDAC1 at
the viral promoter (Figure 4A) correlated with the recruit-
ment of SUV39H1 and HP1 proteins (Figure 6A). To refine
these observations, ChIP experiments using anti-trimethyl-
K9/H3, anti-SUV39H1 and anti-HP1 antibodies were per-
formed in the presence or absence of CTIP2 overexpression
in LTR-LUC-transfected 293T cells (Figure 6B). The control
GAPDH gene promoter, the LTR Nuc-1-binding region
(Figure 6B, PCR2 columns) and the LTR proximal region
(Figure 6B, PCR1 columns) were analyzed by quantitative
real-time PCR.
CTIP2 overexpression and binding (Figure 4B) correlated
with the specific recruitment of HP1a, HP1b and HP1g to the
proximal and to the Nuc-1-binding regions of the HIV-1 LTR
(Figure 6B). Binding of CTIP2 was associated with SUV39H1
recruitment and concomitant increase in K9/H3 methylation
of the adjacent Nuc-1-binding region (Figure 6B). The in-
crease of SUV39H1 association and H3/K9 methylation was
correlated with HIV-1 transcriptional silencing (Figure 4C).
ChIP experiments were then performed in a context of HIV-1-
infected CTIP2 knockdown microglial cells (Figure 6C).
As expected, CTIP2 knockdown correlated with a reduced
presence of SUV39H1 at the Nuc-1- and the Nuc-2-binding
regions of the HIV-1 promoter (Figure 6C, panel
a-SUV39H1). This reduction correlated with a decrease in K9/
H3 trimethylation and release of HP1b and HP1g from Nuc-1
and Nuc-2 nucleosomes (Figure 6C). Surprisingly, in CTIP2
knockdown cells, HP1a binding was only weakly reduced at
the Nuc-1 region and even slightly increased at the Nuc-2
region (Figure 6C, panel a-HP1a). CTIP2 knockdown also led
to a significant increase in Sp1 binding at the Nuc-2 region,
Figure 5 CTIP2 cooperates and associates with HMT SUV39H1 via
its central domain. (A) HEK 293T cells were transfected with the
indicated pFLAG-CTIP2 constructs. Cell extracts were normalized
for the quantities of overexpressed FLAG-CTIP2 proteins and en-
dogenous SUV39H1. Complexes immunoprecipitated with the anti-
SUV39H1 antibodies or the control non-immune serum were im-
munodetected for the presence of FLAG-CTIP2 proteins by Western
blot. (B) GST pull-down assays were performed with 35S-labelled
CTIP2 protein incubated with GST (column 2) or GST-SUV39H1
fusion proteins (column 3). Approximately 10% of the total 35S-
labelled proteins obtained were loaded as input control (column 1).
(C, E) TZM-bl cells were transfected with the indicated vectors. Two
days post-transfection, LUC activities were measured and expressed
relative to the value obtained with the empty vector. (D, F)
Microglial cells were transfected with the indicated vectors. LUC
activities were measured 2 days post-transfection and expressed
relative to value obtained with the LTR-LUC alone taken as 1. DNA
quantities were normalized with the corresponding empty vector.
(G, H) Microglial cells were transfected with the HIV-1 pNL 4-3
vector and the indicated vectors. Two days post-transfection, culture
supernatants were analyzed for p24 Gag contents. The knockdown
efficiency of shRNA constructions was controlled by Western-blot
(Supplement Figure S3).
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suggesting that CTIP2 knockdown-mediated modifications of
the Nuc-2 nucleosome favored Sp1 binding to the adjacent
Sp1-binding sites (Van Lint et al, 1997).
Decreased recruitment of CTIP2, SUV39H1 and HP1 to
the HIV-1 promoter during transcriptional activation
in the latently infected monocytic U1 cell line
To further evaluate the biological relevance of our findings,
we performed quantitative ChIP assays in the monocytic HIV-
1-infected U1 cell line, a model cell line for post-integration
latency. In order to map the molecular flux of all the
components of CTIP2-associated complex at the viral promo-
ter during transcriptional activation, quantitative ChIP assays
were carried out on mock-treated or PMA-treated U1 cells. As
a control for transcriptional activation, these assays revealed
that PMA treatment correlated with enhanced recruitment of
TBP at the viral proximal promoter (Figure 7A). Remarkably,
the viral transcriptional activation by PMA was associated
with dislodgment of CTIP2 from the LTR proximal region
(Figure 7A). In total agreement with our model, displacement
of CTIP2 during transcriptional activation also correlated
with a reduction in the level of SUV39H1 associated with
the proximal region of the viral LTR. Accordingly, H3/K9
methylation of the adjacent Nuc-1 and the downstream Nuc-2
nucleosomes also decreased during PMA-induced transcrip-
tional stimulation (Figures 7B and C). Moreover, CTIP2
release from the viral promoter and Nuc-1/2 hypomethyla-
tion correlated with a general reduction in the levels of HP1b
and HP1g associated with the viral promoter (Figure 7A–C).
Except for the Nuc-2 region (Figure 7C), levels of HP1a
were also reduced after PMA treatment. In contrast, Sp1
levels, which remained unaltered in the proximal and the
Nuc-1 regions, surprisingly increased at the Nuc-2 region
(Figure 7C). This latter observation correlates with that
made after CTIP2 knockdown in microglial cells (Figure 6C,
panel a-Sp1, PCR3)
Altogether, these results demonstrate that CTIP2,
SUV39H1 and HP1 proteins are associated with the HIV-1
promoter proximal region in the context of latent integrated
HIV-1 proviruses in vivo. In contrast, transcriptional activa-
tion of the HIV-1 promoter is associated with the release of
CTIP2, SUV39H1 and HP1 proteins from the viral LTR.
Very recently, CBP/p300 has been shown to be recruited by
Sp1 following PMA treatment (Hung et al, 2006). To further
explore the mechanism of CTIP2 displacement upon PMA
stimulation, we performed time-ChIP experiments targeting
CTIP2, CBP/p300 and Sp1 proteins at the proximal Sp1-
binding sites of the viral promoter. As shown in Figure 7E,
levels of LTR-bound Sp1 remained unchanged after PMA
treatments. Interestingly, CTIP2 displacement was correlated
with concomitant recruitment of CBP. In addition, the relative
amount of lost CTIP2 was very close to the amount of the
newly recruited CBP. This observation thus suggests that
displacement of CTIP2 from Sp1 upon PMA treatment may
allow the recruitment of CBP coactivator. These data further
support the notion that CTIP2 plays an important role in
HIV-1 transcriptional repression by dictating a repressive
chromatin structure in the viral LTR.
Discussion
Microglial cells, the CNS-resident macrophages, are the main
HIV-1 target cells in the brain. Protected by the blood–brain
barrier, microglial cells constitute a major viral reservoir
insensitive to HAART. In a recent study, we reported that
the nuclear cofactor CTIP2 inhibits HIV-1 replication in
Figure 6 CTIP2-mediated recruitment of SUV39H1 to the viral LTR promotes K9/H3 methylation and HP1 recruitments. (A, C) Microglial (A)
and CTIP2 knockdown microglial cells were infected with the VSV-pseudotyped pNL4.3-env virus 24 h before being subjected to ChIP
experiments with the indicated antibodies. As a control, immunoprecipitations were performed in the absence of antibody (Ab control). Input
and immunoprecipitated DNA was subjected to real-time PCR using the PCR1 (A) or PCR2 and PCR3 (C) LTR-specific oligonucleotides. The
amount of immunoprecipitated material was normalized to the input DNA (A) and the fold enrichments were normalized to enrichment in the
nonspecific GAPDH promoter (C). (B) ChIP experiments were performed on HEK 293T cells transfected with the HIV-1 LTR-LUC episomal
vector in the presence or absence of the FLAG-CTIP2 expression vector as indicated. Specific enrichments in HIV LTR regions obtained with the
indicated antibodies were quantified by real-time PCR with the PCR1, PCR2 and GAPDH oligonucleotides. Results were normalized to
enrichment in nonspecific GAPDH DNA. Results are representative of three independent experiments.
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microglial cells by affecting HIV-1 gene transcription by two
different mechanisms. CTIP2 represses the initial phase of
HIV-1 transcription via a direct association with the LTR-
bound transcription factor Sp1 (Marban et al, 2005) and the
late phase via viral Tat protein relocation to transcriptionally
inactive regions of chromatin (Rohr et al, 2003). By forcing
a local heterochromatic environment at the viral promoter,
CTIP2 inhibits HIV-1 replication in human microglial cells,
the main HIV-1 target and reservoir cells of the CNS.
Here, we address the intimate molecular mechanisms where-
by CTIP2 promotes a local heterochromatic environment to
repress HIV-1 gene transcription in microglial cells.
Biochemical analysis revealed that CTIP2 associates with
HDAC1 and HDAC2. HDAC1 and HDAC2 are often found in
association, as illustrated for the HDAC complexes identified
to date (for review, see Ahringer, 2000). Interestingly,
no component of known HDAC1/2 complexes could be
detected in association with CTIP2. This suggests that
CTIP2 could interact directly with HDAC1/2 or as part of
the new HDAC1/2-containing complex. Biochemical purifica-
tion and complete identification of CTIP2-associated proteins
should allow one to discriminate between both hypotheses.
Figure 7 Transcriptional HIV-1 activation is accompanied by a decreased recruitment of CTIP2 and HP1 to the viral proximal promoter in the
chromosomal context of integrated proviruses. ChIP assays were used to detect association of TBP, Sp1, CTIP2, HP1a, HP1b, HP1g, triMeK9/H3
or SUV39H1 with the HIV-1 promoter proximal region (PCR1) (A), the Nuc-1-binding region (PCR2) (B), the Nuc-2-binding region (PCR3) (C)
or the GAPDH promoter (D). U1 cells were mock-treated () or treated (þ ) with PMA (100 nM) for 1 h (A–D) and 20–80 min for time-ChIP
assays (E). The amount of immunoprecipitated material was normalized to the input DNA. (E) U1 cells were mock-treated or treated with PMA
(100 nM) for the indicated times and the proteins were crosslinked with formaldehyde for 10 min and DNA sheared. The crosslinked protein/
DNA complexes were immunoprecipitated with the indicated antibodies or with a purified IgG as negative control. The protein/DNA crosslinks
were reversed and the purified DNA was amplified and quantified by real-time PCR using the PCR1 primer. The amount of immunoprecipitated
material was normalized to the input DNA.
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A previous study has reported that CTIP2 physically and
functionally interacted with SirT1, a human class III
TSA-insensitive HDAC (Senawong et al, 2003). However,
enzymatic assays or Western blot analysis did not allow
us to detect class III members in association with CTIP2
(data not shown).
Expression of truncated forms of CTIP2 and the analysis of
associated HDAC activity revealed that interaction with HDAC
enzymes was mediated by the N-terminus of CTIP2 (aa 1–
145). In previous studies, we reported that the central domain
of CTIP2 (aa 145–434) was involved in interactions with the
cellular Sp1, COUP-TF and the viral Tat proteins, whereas its
C-terminus (aa 717–813) associated with HP1a (Rohr et al,
2003; Marban et al, 2005). CTIP2 does not directly bind to
DNA but is recruited to the HIV-1 promoter via its association
with Sp1. Therefore, association of HDACs with the N-term-
inal region of CTIP2 is fully compatible with the recruitment
of their activity to the HIV-1 promoter. ChIP experiments
confirmed the concomitant recruitment of CTIP2, HDAC1 and
HDAC2 to the viral promoter in infected microglial cells.
Overexpression of CTIP2 promoted HDAC1 and HDAC2
recruitment to the viral promoter. Moreover, CTIP2-mediated
recruitment of HDAC1/2 to the viral promoter was correlated
with local deacetylation of H3. These observations indicate
that HDAC1 and HDAC2 interact with CTIP2 anchored to the
HIV-1 LTR and suggest that HDAC enzymes collaborate with
CTIP2 for HIV-1 gene silencing. We confirmed in HIV-1-
infected CTIP2 knockdown cells the need of CTIP2 recruit-
ment for HDAC2 association with the viral promoter.
However, as HDAC1 recruitment was increased after CTIP2
knockdown, it should be further recruited by other molecular
interactions favored by CTIP2 displacement, such as direct
association with Sp1 (Doetzlhofer et al, 1999). Here, we show
that both HDAC enzymes cooperate with CTIP2 to repress
HIV-1 transcription in integrated or episomal contexts.
Remarkably, the best cooperations were observed in the
provirus context, suggesting the need of the whole HIV-1
genome to have the best-chromatinized structure and the
more physiological view of these phenomena. These results
confirm the biological relevance of the association between
CTIP2 and HDACs that we unravel in this study. In addition,
they imply that both HDAC1 and HDAC2 are necessary for
CTIP2 repressive function and contribute to the establish-
ment of a repressive state of HIV-1 gene transcription in
microglial cells. Quantification of the HIV-1 gene transcripts
revealed that CTIP2 repressed their initiation but not elonga-
tion. Very recently, the same observation was made for the
NF-kB p50 factor that also recruits HDAC1 to the HIV-1
promoter (Williams et al, 2006).
In contrast to histone acetyltransferases (HATs), there have
been few articles to report HDAC recruitment to the HIV-1
promoter. The HIV-1 transcriptional repressors YY1 and LSF
have been shown to recruit HDAC1 (Coull et al, 2000).
Blocking LSF-mediated recruitment of HDAC1 to the HIV-1
promoter produced a rebound of HIV-1 replication in resting
CD4þ T cells from HIV-infected patients whose viremia had
been suppressed by therapy (Ylisastigui et al, 2004). These
results are in favor of a role for TSA-sensitive HDACs in the
establishment of persistent and quiescent reservoir of HIV-1
infection. Thus, understanding HDAC recruitment to HIV-1
promoter is crucial for developing strategies to purge the
quiescent reservoir and eradicate the virus.
We previously reported that CTIP2 recruited HP1a to the
HIV-1 promoter. In heterochromatic environment, HP1 pro-
teins specifically interact with the methylated forms of his-
tone H3 lysine 9 (Bannister et al, 2001). As CTIP2-mediated
recruitment of HDAC1 and HDAC2 induced K9/H3 deacetyla-
tion, we further investigated the ability of CTIP2 to associate
with HMT activity. Co-immunoprecipitation experiments
revealed that CTIP2 associates with the HMT SUV39H1. ChIP
experiments confirmed the concomitant association of CTIP2
and SUV39H1 on the HIV-1 promoter in infected microglial
cells. Moreover, we observed CTIP2-mediated recruitment of
SUV39H1 to the viral LTR and the concomitant methylation of
K9/H3 to the HIV-1 Nuc-1-binding region. In eukaryotic cells,
lysine 9 of histone H3 is specifically methylated by SUV39H1
(Rea et al, 2000) creating a binding site for the chromo-
domain of HP1 (Bannister et al, 2001; Lachner et al, 2001).
Targeting HP1 to chromatin also requires direct physical
interaction with SUV39H1 (Stewart et al, 2005). Here, we
reveal that CTIP2 can recruit SUV39H1 and HP1a, HP1b and
HP1g proteins to the viral promoter. Interestingly, CTIP2
knockdown induces a decreased recruitment of HP1b and
HP1g but not HP1a to the Nuc-1 and Nuc-2 regions.
Stimulation of the latently infected U1 cells by PMA did not
release Hp1a from the Nuc-2 region. These results suggest
that the establishment of transcriptional latency induced by
CTIP2 and the transcriptional reactivation are not strikingly
linked by reversal molecular mechanisms. Moreover, it also
suggests that distinct roles could be attributed to the different
isoforms of HP1 proteins. Interestingly, SUV39H1 has been
shown to associate with many other proteins, including
HDACs. HDAC1, HDAC2 and HDAC3 were shown to associate
with SUV39H1, suggesting that transcriptional repression by
SUV39H1 could be the consequence of HDAC recruitment
(Vaute et al, 2002). Moreover, methylation of K9/H3 can
suppress transcription independently of HP1 through a
mechanism involving histone deacetylation (Stewart et al,
2005). Altogether, HDAC1, HDAC2, SUV39H1 and HP1 pro-
teins are deeply involved in the formation of heterochromatic
environments and gene silencing. Moreover, in the context of
latently infected cells, transcriptional activation of the HIV-1
promoter is accompanied by a decreased recruitment of
CTIP2, SUV39H1, HP1 proteins and K9/H3 methylation.
Moreover, as CTIP2-induced modifications appeared propa-
gated to the downstream Nuc-2 region, it suggests that this
heterochromatic structure can spread along the viral genome.
In addition, displacement of CTIP2 from Sp1 upon PMA
stimulation and the subsequent recruitment of the CBP
coactivator further confirm the notion that CTIP2 plays an
important role in HIV-1 transcriptional repression by dictating
a repressive chromatin structure at the viral LTR.
The present work strongly suggests the concomitant re-
cruitment of HDAC1, HDAC2 and SUV39H1 enzymes to the
viral promoter by CTIP2. The ordered histone modifications
would allow HP1 binding, heterochromatin formation and
HIV-1 silencing (Figure 8). As heterochromatin formation at
the HIV-1 promoter has been linked to post-integration
latency, it suggests a possible involvement of transcriptional
repressors such as CTIP2 in the establishment of viral persis-
tence and post-integration latency in the brain. Therefore, our
findings uncover new therapeutic opportunities for purging
latent HIV-1 viruses from their cellular sanctuaries in infected
patients.
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Materials and methods
Plasmids
Most of the constructs used in our assays have been described
previously: pcDNA3, GST-CTIP2 and full-length construct pFLAG-
CTIP2 1–813 (Avram et al, 2000); pNL4-3, pNL4.3-env, pVSV.G and
deletions constructs pFLAG-CTIP2 (Rohr et al, 2003); pRFP-CTIP2
(Marban et al, 2005); pcDNA3-HDAC1, pcDNA3-HDAC2 and
pcDNA3-HDAC3 expression vectors (Fischle et al, 1999). pshRNA-
HDACs were provided by MA Lazar (Ishizuka and Lazar, 2003)
and pMyc-SUV39H1, pshRNA-SUV39H1 and pGST-SUV39H1 by
T Jenuwein (Schotta et al, 2004). The episomal LTR-LUC vector was
constructed by cloning the luciferase gene under the control of the
HIV-1 LTR into a modified pREP10 episomal vector. pshRNA-CTIP2
and pSirenZsGreen-shRNA-CTIP2 were constructed by inserting the
sequence directed against CTIP2 in the pSuper plasmid (Oligoen-
gine Inc.) or the pSirenZsGreen RetroQ vector (Clontech Lab. Inc.)
as recommended by the manufacturer.
Cell culture
The human microglial cell line (provided by M Tardieu, Paris,
France) (Janabi et al, 1995), TZM-bl (Derdeyn et al, 2000; Wei et al,
2002), U1 and HEK 293T cell lines were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% fetal calf serum
and 100 U/ml penicillin–streptomycin. CTIP2 knockdown microglial
cells expressing shRNA-CTIP2 were stably established by infection
of microglial cells with a pSirenZsGreen-ShRNA-CTIP2-based retro-
virus as described by the manufacturer (Clontech Lab. Inc.). CTIP2
shRNA-expressing cells were sorted by flow cytometry for the
concomitant expression of the ZsGreen protein and cultured in
DMEM. The CTIP2 knockdown efficiency was controlled by
quantitative RT–PCR and ChIP experiments.
GST pull-down assays
Production of GST fusion proteins was described previously (Rohr
et al, 1997). The 35S-labelled SUV39H1 was prepared by in vitro
transcription–translation using the TNTs T7 Coupled Wheat Germ
Extract System (Promega). GST pull-down assays were performed
essentially as described previously (Rohr et al, 2003).
Co-immunoprecipitation assays
HEK 293T cells cultured in 100-mm-diameter dishes were trans-
fected using the calcium phosphate co-precipitation method with
the indicated pFLAG-CTIP2 deletion constructs (30 mg) or pcDNA3
(30mg) vectors. Two days post-transfection, immunoprecipitations
were performed using the standard technique with M2 anti-FLAG
(Sigma) or the anti-SUV39H1 (Santa Cruz) antibodies overnight at
41C. Finally, the immunoprecipitated complexes were processed for
SDS–PAGE and Western blot analysis or HDAC assays.
Histone deacetylase assays
The immunoprecipitated complexes were washed twice with HDAC
buffer (10 mM Tris–HCl, pH 8.0, 10 mM NaCl, 10% glycerol). For
inhibition studies, they were preincubated with TSA (450 nM) in
HDAC buffer for 45 min at 41C. Beads were resuspended in 30ml of
HDAC buffer containing 20 000 c.p.m. of an acetylated H4 peptide.
HDAC activity was determined after incubation for 2 h at 371C. The
reaction was stopped by adding 0.04 M acetic acid and 250 mM HCl.
The mixture was extracted with ethyl acetate and the released
[3H]acetic acid was quantified by scintillation counting.
SDS–PAGE and Western blot analysis
SDS–PAGE were performed using standard techniques. Proteins
were detected using antibodies directed against the FLAG epitope
(M2 mouse monoclonal from Sigma), HDAC1, HDAC2 and HDAC3
proteins (Santa Cruz), CTIP2 (abcam), Myc epitope (Santa Cruz)
and b-actin (Sigma). Proteins were visualized by chemilumines-
cence using the Super Signal Chemiluminescence Detection System
(Pierce).
Luciferase assays
Microglial and TZM-bl cells cultured in 48-well plates were
transfected with the indicated vectors using the calcium phosphate
co-precipitation method. Two days later, cells were collected and
luciferase activity was determined using the Dual-GloTM Luciferase
Assay System (Promega). Values correspond to an average of at
least three independent experiments performed in duplicate.
Viral replication
Microglial cells cultured in 12-well plates were transfected using the
calcium phosphate co-precipitation method with HIV-1 pNL4-3 and
the expression plasmids as indicated. Total amounts of DNA were
normalized with the corresponding empty vector. HIV-1 replication
was monitored as described previously (Rohr et al, 2003). Values
correspond to an average of at least three independent experiments
carried out in duplicate.
Pseudotyped virion production and single-round infection
The plasmid pNL4.3-env was cotransfected with the envelope
plasmid encoding the pVSV.G envelope protein into HEK 293Tcells.
The virions were collected 48 h post-transfection. For single-round
infection, microglial cells were incubated with the VSV-pseudo-
typed HIV-1 NL4.3-env virus for 24 h at 371C.
Chromatin immunoprecipitation assays
Microglial and CTIP2 knockdown microglial cells cultured in 150-
mm-diameter dishes were subjected to single-round infection by the
VSV-pseudotyped viruses 24 h before being processed for ChIP
experiments. HEK 293T cells cultured in 100-mm-diameter dishes
were transfected using the calcium phosphate co-precipitation
method with the indicated vectors. ChIP assays were performed
using the ChIP assay kit (Upstate) 48 h post-transfection. To reach
the desired resolution, we have optimized our sonication procedure
to obtain 100–150 bp DNA fragments. U1 cells were mock-treated
() or treated (þ ) with PMA (100 nM) for 1 h (20–80 min for the
time-ChIP experiments) before ChIP assays. The primary antibodies
used for ChIP were as follows: M2 anti-FLAG (Sigma), anti-CTIP2
(Abcam), anti-Sp1 (Upstate), anti-TBP (Upstate), anti-HDAC1,
anti-HDAC2, anti-Ac/H3, anti-triMeK9/H3, anti-HP1a (Upstate)
anti-HP1b (Euromedex), anti-HP1g (Euromedex), anti-SUV39H1
(Abcam) and anti-CBP (Santa Cruz Biotech.). Immunoprecipitated
DNA was subjected to real-time PCR quantification. Three LTR-
HIV-1 regions were selected for amplification (PCR1, PCR2 and
PCR3) as well as the human constitutively expressed cellular gene
for GAPDH. Primers are presented in Supplementary Figure 6.
Initiation and elongation quantification
Quantification of the initiated and the elongated HIV-1 gene
transcripts was performed in infected control and shRNA-CTIP2-
expressing microglial cells by real-time RT–PCR quantification, as
described previously (Williams et al, 2006). Results were normal-
ized to the b-actin copies.
Figure 8 Model for CTIP2-mediated establishment of heterochromatin environment to HIV-1 gene promoter and viral silencing. CTIP2 first
recruits HDAC1 and HDAC2 enzymes to deacetylate H3 histones located at the viral promoter and particularly Nuc-1 H3 histones. After H3
deacetylation, CTIP2 recruits SUV39H1 to methylate Nuc-1 histone H3 lysine 9. This last H3 modification allows HP1 binding and
polymerization, heterochromatin formation and HIV-1 silencing.
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Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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